About this trial
This randomized clinical trial evaluates the effect of combining magnesium supplementation with an orthodontic technique called Alternate Maxillary Expansion and Constriction (Alt-RAMEC) using a Micro-implant Assisted Rapid Palatal Expansion (MARPE) appliance to treat adults (18-30 years) with transverse maxillary deficiency (TMD). TMD is a condition where the upper jaw is narrower than normal, which can affect bite and facial development.
The study involves two groups: one receiving the Alt-RAMEC protocol with MARPE alone, and the other receiving the same protocol alongside oral magnesium supplements. The effectiveness of these treatments will be compared by assessing changes in dental and skeletal structures through imaging techniques and evaluating muscle function. Participants will also report their pain and discomfort levels during the treatment.
This research aims to understand whether magnesium supplementation can enhance the effects of Alt-RAMEC treatment, improve patient outcomes, and reduce discomfort associated with orthodontic procedures.
Eligibility criteria
Qualifiers
Inclusion Criteria
All participants were young adults, from the 18- 25 age group (males or females).
There is a maxillary skeletal deficiency in every patient. (Anteroposterior deficiency, transverse bilateral/unilateral deficiency)
All teeth erupted without any abnormalities in term of shape and size.
Disqualifiers
History of previous orthodontic treatment or maxillary expansion
Patients with severe progressive periodontal disease
Patients with severe craniomaxillofacial deformities such as cleft lip and palate
Mid palatal fusion without successful expansion
Trial design
Treatments tested in this trial
- magnesium citrate
- Magnesium